Indolent Systemic Mastocytosis Ism clinical trials

Explore recruiting indolent systemic mastocytosis ism clinical trials.

Recruiting indolent systemic mastocytosis ism studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Indolent Systemic Mastocytosis Ism trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A 3-Part, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate Safety and Efficacy of Avapritinib (BLU 285), a Selective KIT Mutation-Targeted Tyrosine Kinase Inhibitor, in Indolent and Smoldering Systemic Mastocytosis with Symptoms Inadequately Controlled with Standard Therapy

France, Netherlands, Denmark, Sweden, Germany, Italy +3 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Indolent Systemic Mastocytosis Ism trials by city

Indolent Systemic Mastocytosis Ism in Toronto Indolent Systemic Mastocytosis Ism in Vancouver Indolent Systemic Mastocytosis Ism in Montreal Indolent Systemic Mastocytosis Ism in Calgary Indolent Systemic Mastocytosis Ism in Edmonton Indolent Systemic Mastocytosis Ism in Ottawa Indolent Systemic Mastocytosis Ism in Winnipeg Indolent Systemic Mastocytosis Ism in Quebec City Indolent Systemic Mastocytosis Ism in Hamilton Indolent Systemic Mastocytosis Ism in Kitchener Indolent Systemic Mastocytosis Ism in London Indolent Systemic Mastocytosis Ism in Halifax Indolent Systemic Mastocytosis Ism in New York Indolent Systemic Mastocytosis Ism in Los Angeles Indolent Systemic Mastocytosis Ism in Chicago Indolent Systemic Mastocytosis Ism in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease